111 Price to Sales Ratio 2018-2024 | YI

Historical PS ratio values for 111 (YI) over the last 10 years. The current P/S ratio for 111 as of March 11, 2025 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
111 P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2025-03-11 8.10 0.03
2024-09-30 0.76 $241.16 0.00
2024-06-30 1.07 $240.89 0.00
2024-03-31 1.16 $242.97 0.00
2023-12-31 1.55 $250.23 0.01
2023-09-30 2.60 $248.64 0.01
2023-06-30 2.46 $245.69 0.01
2023-03-31 2.65 $243.07 0.01
2022-12-31 3.02 $235.30 0.01
2022-09-30 2.68 $235.75 0.01
2022-06-30 2.06 $241.86 0.01
2022-03-31 2.66 $243.92 0.01
2021-12-31 3.50 $235.18 0.01
2021-09-30 6.17 $222.39 0.03
2021-06-30 9.09 $202.02 0.04
2021-03-31 13.80 $173.39 0.08
2020-12-31 6.95 $152.64 0.05
2020-09-30 6.20 $120.68 0.05
2020-06-30 6.35 $97.40 0.07
2020-03-31 6.61 $84.45 0.08
2019-12-31 6.73 $69.33 0.10
2019-09-30 4.87 $61.90 0.08
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.072B $2.105B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $36.709B 54.09
Hims & Hers Health (HIMS) United States $11.210B 183.25
Tempus AI (TEM) United States $10.954B 0.00
Inspire Medical Systems (INSP) United States $5.532B 107.78
IRhythm Technologies (IRTC) United States $3.734B 0.00
Privia Health (PRVA) United States $2.941B 245.10
Enovis (ENOV) United States $2.475B 16.49
Clover Health Investments (CLOV) United States $2.095B 0.00
Azenta (AZTA) United States $2.083B 96.98
Omnicell (OMCL) United States $1.845B 40.23
Schrodinger (SDGR) United States $1.580B 0.00
Phreesia (PHR) United States $1.577B 0.00
10x Genomics (TXG) United States $1.381B 0.00
Butterfly Network (BFLY) United States $0.859B 0.00
Fulgent Genetics (FLGT) United States $0.512B 0.00
Standard BioTools (LAB) United States $0.495B 0.00
Talkspace (TALK) United States $0.481B 285.00
TruBridge (TBRG) United States $0.423B 123.26
Nyxoah SA (NYXH) Belgium $0.353B 0.00
Pulmonx (LUNG) United States $0.352B 0.00
Health Catalyst (HCAT) United States $0.305B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.257B 0.00
American Well (AMWL) United States $0.174B 0.00
EUDA Health Holdings (EUDA) Singapore $0.097B 0.00
MDxHealth SA (MDXH) Belgium $0.085B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
CareCloud (CCLD) United States $0.054B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Outset Medical (OM) United States $0.044B 0.00
Zepp Health (ZEPP) China $0.042B 0.00
SHL Telemedicine (SHLT) Israel $0.038B 0.00
Zhongchao (ZCMD) China $0.034B 0.00
Movano (MOVE) United States $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.015B 0.00
Precipio (PRPO) United States $0.014B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Syra Health (SYRA) United States $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00